Shedding after starting minoxidil or finasteride: is it normal, how long does it last, and when is that not the explanation?

Shedding at the start of treatment is the extra hair loss some people notice in the first weeks of a hair-loss treatment. On forums it goes by the name shedding, or “dread shed”. It's understandable that it's scary, since it looks like more hair is falling out because of the very thing you started to fight the loss.

How much we know about this differs a lot between the two most common drugs. For minoxidil, the British Regaine 5% summary of product characteristics (the authority-approved professional text) describes in a separate paragraph that some users reported increased shedding at the start of treatment.1 For finasteride we found no such thing: it isn't listed in Propecia 1 mg's summary of product characteristics' side effect list, and we didn't find a trial specifically aimed at this either.2

What you can take from this: the initial shed is a described phenomenon for minoxidil, and an open question for finasteride, one we found no measured answer to.

Per the summary of product characteristics, the most likely reason is that minoxidil tips resting hairs into growth: the old hair falls out, and a new one grows in its place.1 Hair lives in a cycle. A hair grows for years (this is the anagen, growth phase), then rests (this is the telogen, resting phase), and finally falls out. The new hair starts under the resting hair, and pushes the old one out.3 If many follicles restart at once, the old hairs also fall out at once, and this looks like extra shedding. I've described minoxidil's mechanism of action in the minoxidil article.

Telogen effluvium (sudden, scattered hair loss triggered by a strain on the body) affects the same cycle, in the opposite direction: there, the strain sends growing hairs into rest, and the resting hairs fall out.3 Common triggers are a feverish illness, major surgery, postpartum hormone changes, an underactive thyroid, drastic dieting, iron deficiency, and certain medications.3

What you can take from this: with the initial shed, the resting hairs restart; with telogen effluvium, the growing ones stop; and timing helps tell the two apart.

Per the Regaine 5% summary of product characteristics, this transient extra shedding generally appears 2 to 6 weeks after starting treatment, and settles within a few weeks. The label also states that if the shedding lasts more than two weeks, use should be stopped and a doctor consulted.1

Two limits go with this. The label bases the phenomenon on user reports, and in its side effect table the frequency of the transient hair loss is “not known”, meaning it can't be estimated from the available data.1 This timeline is from the label of the 5 percent solution applied to the scalp, and doesn't carry over to oral minoxidil. I didn't review the labels of the minoxidil products sold in Hungary for this, the sentences above are from the British label.

It takes longer to see a sign of the effect. Per Regaine's label, signs of hair growth can take two months or more of twice-daily use, and per Propecia's label, signs of the shedding stabilising can take 3 to 6 months of daily use.12 The common forum advice to “wait out the 3 to 6 months” fits judging the effect; for the duration of the shedding, the label gives a much shorter time. What you can take from this: minoxidil's initial shed is, per the label, measured in weeks; what lasts for months no longer fits that description.

We found scant, weak data on the frequency of the initial shed: three trials, none of them placebo-controlled, and each counting something different. Shukla and colleagues (2026) followed 200 men aged 18 to 40 with patterned hair loss for two months between February 2019 and August 2020 at a medical college and hospital in Indore, India, treated with 5 percent minoxidil; other causes of hair loss were excluded. 11 percent of participants reported increased shedding alone, and per the abstract a further 14 percent reported increased shedding together with a dry scalp; this second figure isn't repeated in the results section.4 There was no control group, and the paper doesn't say whether the shedding was actually counted.

Zari (2023) looked back at the records of 400 patients with patterned hair loss at a private clinic in Jeddah (Saudi Arabia) who used 2 or 5 percent minoxidil applied to the scalp; two-thirds were women. 9.8 percent of patients reported increased hair shedding, based on a questionnaire; the paper doesn't say when it appeared.5 Nohria and colleagues (2024) reviewed the charts of 115 patients on low-dose oral minoxidil at a New York academic dermatology practice, 55 percent of them women; among them, 5.2 percent had new shedding appear after starting the tablet, based on the patients' own reports.6 This data is about the oral form, and doesn't carry over to the solution applied to the scalp.

In the two trials on minoxidil applied to the scalp, roughly 10 to 25 percent reported increased shedding; the upper figure is from the Indian abstract, and also includes those who reported shedding together with a dry scalp.45 For the oral form, per the Nohria paper, rates of 2.4 to 22 percent were previously reported, and the authors call their own 5.2 percent lower than what was previously reported.6 What you can take from this: none of the trials show how much is down to the drug and how much to hair loss's natural fluctuation.

We found no measured data on this. During evidence gathering, we searched the international literature database (Europe PMC) for finasteride's initial shed, and found no clinical trial or case series that specifically studied it. Propecia 1 mg's summary of product characteristics doesn't list extra shedding in its side effect list either.2 What follows from this is that we have no measurement on it; whether it occurs is an open question.

The closest thing there is: Propecia's label describes a 48-week, placebo-controlled trial in 212 men that specifically looked at the phases of the hair cycle on the crown. In those taking finasteride, the number of hairs in the growth phase increased, those on placebo lost such hairs, and the label concludes from this that finasteride pushes follicles towards the growth phase. But the hairs were only counted at the start and at week 48, this trial says nothing about the first weeks.2

If you started finasteride and minoxidil at the same time, the documented description of the initial shed belongs to minoxidil; which drug is doing what in your case can't be decided from this. I've written about the tablet in the oral DHT blockers article, and about the form sprayed onto the scalp in the topical finasteride article. Ask your doctor this: “if the shedding gets worse with finasteride, when and with what test should we look into the cause?”

Per Regaine's label, minoxidil is only for patterned hair loss, and must not be used if the shedding is sudden or patchy, started after childbirth, there's no family history of hair loss, or it's not known what's causing it.1 In such cases, the trigger needs to be found. I've described telogen effluvium's causes, timing and work-up in the telogen effluvium article.

Timing is telling too. If the shedding was already getting worse before treatment, or started months after starting, that doesn't fit minoxidil's label timeline. In such cases it's worth thinking through what happened to you before the shedding: illness, surgery, childbirth, dieting, or a new medication.

See a doctor if the extra shedding lasts more than two weeks; if it's patchy or sudden; if your scalp is inflamed, infected, irritated or painful, because per the label minoxidil must not even be applied to such a scalp;1 or if the shedding gets worse alongside finasteride, because there's no described, expected timeline for that. What you can take from this: three questions tell the two apart, when it started, what its pattern is, and how long it lasts.

For minoxidil, per Regaine's label, you should stop and see a doctor if the extra shedding lasts more than two weeks.1 For finasteride, the label gives no such instruction. It states that signs of the shedding stabilising take 3 to 6 months of daily use, and that after stopping, the beneficial effect starts to reverse within 6 months.2 I've described what happens after stopping in the finasteride discontinuation article.

The decision is yours and your treating doctor's. Ask your doctor this: “does the current shedding fit the initial phase, or does its cause need a work-up?”

Microneedling is a mechanical stimulus with no hormonal effect, so it can be used alongside medications that act on DHT. Dermastamp is a fixed 1 mm, at-home device: the needle stimulates the area around the follicle, and its mechanism doesn't touch DHT. This is inferred from the mechanism, not measured. You don't skip oral finasteride or dutasteride on the day of stamping. With scalp-applied products, the day of stamping is a pause, and the exact timing differs by product: the timing of actives. For anyone who'd rather not touch their hormones, this is a route that stays open, with one limitation: in the study measuring the combination, both groups also received minoxidil, and the study used a 1.5 mm clinical roller, not our fixed 1 mm device; there's less data for standalone use. What it can do, what it can't, and who it's not for: I've written it all on its page.

See Dermastamp